Lung ultrasound and high-resolution computed tomography quantitative variations during nintedanib treatment for systemic sclerosis-associated interstitial lung disease

被引:2
|
作者
Di Battista, Marco [1 ,2 ,6 ]
Delle Sedie, Andrea [1 ]
Romei, Chiara [3 ]
Tavanti, Laura [4 ]
Da Rio, Mattia [1 ]
Morganti, Riccardo [5 ]
Della Rossa, Alessandra [1 ]
Mosca, Marta [1 ]
机构
[1] Univ Pisa, Rheumatol Unit, Pisa, Italy
[2] Univ Siena, Dept Med Biotechnol, Siena, Italy
[3] Univ Pisa, Radiol Unit, Pisa, Italy
[4] Univ Pisa, Cardiovasc Thorac Dept, Pisa, Italy
[5] Univ Hosp, Sect Stat, Pisa, Italy
[6] Univ Pisa, Rheumatol Unit, Via Roma 67, I-56123 Pisa, Italy
关键词
systemic sclerosis; nintedanib; interstitial lung disease; lung ultrasound; quantitative HRCT; PULMONARY-FIBROSIS; COMETS;
D O I
10.1093/rheumatology/kead642
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Lung ultrasound (LUS) and high-resolution CT (HRCT) are commonly used for the evaluation of interstitial lung disease (ILD). Nintedanib (NIN) is an antifibrotic therapy approved for systemic sclerosis-associated ILD (SSc-ILD). We assessed LUS and quantitative HRCT changes in SSc-ILD patients treated with NIN during a 1 year follow-up, evaluating relationships between imaging variations and functional or quality-of-life outcomes.Methods: SSc-ILD patients who started NIN were enrolled and followed for 12 months. Pulmonary function tests and patient-reported outcome measures (PROMs) were assessed half-yearly and quarterly, respectively. LUS was performed quarterly evaluating the presence of B-lines (BL) and pleural line irregularities (PLI). HRCT was repeated after 1 year and quantitatively analysed with CALIPER software.Results: Ten patients (70% female, mean age 62 years) were enrolled. The mean total number of both BL and PLI was constantly decreased during NIN treatment, being significantly reduced after 12 months (from 175.1 [66.7] to 120.8 [70.3] for BL, P = 0.005; and from 50.6 [32.5] to 37.2 [22.4] for PLI, P = 0.05). Male gender, smoking habit and baseline forced vital capacity <70% predicted were associated with worse LUS outcomes. A greater reduction in both BL and PLI was observed in those who improved in PROMs, especially modified Medical Research Council dyspnoea scale (P = 0.016 and P = 0.04, respectively) and Saint George's Respiratory Questionnaire (P = 0.006 and P = 0.026, respectively). No significant changes in the CALIPER percentages of normal parenchyma or ILD elements were observed after 12 months of NIN, thus paralleling the stabilization obtained at pulmonary function tests.Conclusion: We present preliminary results on NIN effects on SSc-ILD as assessed by LUS, a useful method for frequently repeated monitoring, and CALIPER, a valid implementation whenever a HRCT is performed.
引用
收藏
页码:3091 / 3097
页数:7
相关论文
共 50 条
  • [1] Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease
    Yamasaki, Yoshioki
    Kuwana, Masataka
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (06) : 547 - 560
  • [2] Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography
    Khanna, Dinesh
    Distler, Oliver
    Cottin, Vincent
    Brown, Kevin K.
    Chung, Lorinda
    Goldin, Jonathan G.
    Matteson, Eric L.
    Kazerooni, Ella A.
    Walsh, Simon L. F.
    McNitt-Gray, Michael
    Maher, Toby M.
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2022, 7 (03) : 168 - 178
  • [3] Treatment of systemic sclerosis-associated interstitial lung disease
    Prasse, A.
    Bonella, F.
    Mueller-Ladner, U.
    Witte, T.
    Hunzelmann, N.
    Distler, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (03): : 294 - 303
  • [4] Lung Ultrasound for Assessment of Interstitial Lung Disease in Systemic Sclerosis: Relationship With High-Resolution Computed Tomography and Nailfold Capillaroscopy
    Elziaty, Rahma A.
    Aboelyazeed, Alaa A.
    Hegazy, Sherif N. A.
    Khalifa, Ahmed A.
    Khalil, Salma A.
    CLINICAL MEDICINE INSIGHTS-ARTHRITIS AND MUSCULOSKELETAL DISORDERS, 2025, 18
  • [5] LUNG ULTRASOUND CHANGES COMPARED WITH AUTOMATED QUANTITATIVE COMPUTED TOMOGRAPHY FOR DETECTING SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Beigi, D. M. Reza
    Pellegrino, G.
    Landini, N.
    Mattone, M.
    Paone, G.
    Truglia, S.
    Di Ciommo, F. R.
    Bisconti, I.
    Cadar, M.
    Stefanantoni, K.
    Panebianco, V.
    Conti, F.
    Riccieri, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 965 - 965
  • [6] Lung ultrasound compared to computed tomography detection and automated quantification of systemic sclerosis-associated interstitial lung disease: preliminary study
    Mohammad Reza Beigi, Davide
    Pellegrino, Greta
    Loconte, Michele
    Landini, Nicholas
    Mattone, Monica
    Paone, Gregorino
    Truglia, Simona
    Di Ciommo, Francesca Romana
    Bisconti, Ilaria
    Cadar, Marius
    Stefanantoni, Katia
    Panebianco, Valeria
    Conti, Fabrizio
    Riccieri, Valeria
    RHEUMATOLOGY, 2024, 63 (05) : 1240 - 1245
  • [7] Spontaneous pneumothorax during nintedanib therapy in patients with systemic sclerosis-associated interstitial lung disease
    Sumi, Toshiyuki
    Uehara, Hirofumi
    Tada, Makoto
    Keira, Yoshiko
    Kamada, Koki
    Shijubou, Naoki
    Yamada, Yuichi
    Nakata, Hisashi
    Mori, Yuji
    Chiba, Hirofumi
    RESPIROLOGY CASE REPORTS, 2021, 9 (03):
  • [8] Systemic sclerosis-associated interstitial lung disease
    Scallan, Ciaran J.
    Collins, Bridget F.
    Raghu, Ganesh
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (05) : 487 - 495
  • [9] Treatment for systemic sclerosis-associated interstitial lung disease
    Roofeh, David
    Lescoat, Alain
    Khanna, Dinesh
    CURRENT OPINION IN RHEUMATOLOGY, 2021, 33 (03) : 240 - 248
  • [10] High-Resolution Computed Tomographic Findings in Systemic Sclerosis-Associated Interstitial Lung Disease Comparison Between Diffuse and Limited Systemic Sclerosis
    Patiwetwitoon, Sumawadee
    Wangkaew, Suparaporn
    Euathrongchit, Juntima
    Kasitanon, Nuntana
    Louthrenoo, Worawit
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2012, 18 (05) : 229 - 233